But for the U.S. pharmaceutical company — which shelved its planned facility meant to support early-stage life sciences businesses with lab space, mentorship and potential financial backing — the proposal alone is not enough.
“I…
Britain’s plan to raise NHS drug prices won’t bring back Lilly’s investment – POLITICO
